| Barchart Demo Center |
$146,67
+1,39 (+0,96%)
en date du mai 31, 2024
en date du mai 31, 2024
| Dernière | 146,67 |
|---|---|
| Variation | +1,39 (+0,96%) |
| Ouverture | 145,57 |
| Clôture précédente | 145,28 |
| Écart (actuel) |
145,19
147,48
|
| Écart 52 semaines |
143,13
175,97
|
| Volume | 14 621 199 |
| Volume Moyen | 7 584 240 |
| Secteur | SIC-2834 Pharmaceutical Preparations |
Perfomance Comparison
| Nom | Aujourd'hui | 3-mois | 1 an |
|---|---|---|---|
| JNJ |
 +0,96% |
 -5,84% |
 -4,98% |
| DJIA |
 +1,51% |
-2,09% |
+16,90% |
| S&P 500 |
+0,80% |
+1,01% |
+25,49% |
Statistiques clef
| BPA Annuel | 16,04 |
|---|---|
| Rendement dividendes | 3,43% |
| Rapport Prix/Bénéfices | 13,81 |
| Market Capitalization, $K | 347 620 750 |
| Alpha pondéré | -9,02 |
| Écart-type | +0,86 |
| Marge d'exploitation | 45,26% |
| Beta | 0,55 |
Taux de croissance
| Cette année | -6,42% | |||
| 1 An(s) | -6,56% | |||
| 3 An(s) | -11,63% | |||
| 5 An(s) | +5,86% | |||
| 10 An(s) | +44,56% |
Opinion
| Vendre | Conserver | Acheter |
Articles récents
Johnson & Johnson Completes Acquisition of Shockwave
Business Wire - Fri May 31, 07:45AM CDT
Johnson & Johnson (NYSE: JNJ) today announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson & Johnson and will operate as a business unit within Johnson & Johnson MedTech.(version intégrale)
JNJ: 146,67 (+1,39)
Sarepta Therapeutics Set to Join S&P MidCap 400
PR Newswire - Wed May 29, 04:48PM CDT
/PRNewswire/ -- Sarepta Therapeutics Inc. (NASD: SRPT) will replace Shockwave Medical Inc. (NASD: SWAV) in the S&P MidCap 400 effective prior to the opening of...(version intégrale)
Johnson & Johnson to Obtain Rights to a Clinical-Stage
Business Wire - Tue May 28, 06:30AM CDT
Johnson & Johnson (NYSE: JNJ) announced today it has entered into a definitive agreement with Numab Therapeutics, a clinical-stage biotechnology company advancing a pipeline of immunology and oncology therapeutics, to acquire from(version intégrale)
JNJ: 146,67 (+1,39)
The Dow closed above 40,000 for the first time. The
AP - Fri May 17, 03:54PM CDT
Through its long history, the Dow Jones Industrial Average has offered a way for people to get a quick read on how Wall Street is doing(version intégrale)
JNJ: 146,67 (+1,39), AMGN: 305,85 (+4,85), JPM: 202,63 (+3,30), GS: 456,52 (+6,29), AXP: 240,00 (+2,78), MSFT: 415,13 (+0,46)
Johnson & Johnson to Acquire Proteologix, Inc. to Lead
Business Wire - Thu May 16, 06:30AM CDT
Johnson & Johnson (NYSE: JNJ) announced today that it has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, for (version intégrale)
JNJ: 146,67 (+1,39)